Skip to main content

Table 2 Summary ORs and 95% CIs of TNF-α polymorphism and osteoarthritis

From: Meta-analysis of tumor necrosis factor alpha -308 polymorphism and knee osteoarthritis risk

Analysis

n

Dominant model(GA + AA vs.GG)

Recessive model(AA vs.GG + GA)

A allele vs. G allele

OR(95% CI)

P/Phet

OR(95% CI)

P/Phet

OR(95% CI)

P/Phet

Overall

7

2.45(0.95-6.27)

0.06/0.00

11.08(4.75-25.86)

0.00/0.25

2.30(1.08-4.90)

0.03/0.00

Ethnicity

       

Caucasian

2

1.37(0.89-2.10)

0.14/0.92

6.99(0.70-69.68)

0.10/0.66

1.42(0.96-2.09)

0.08/0.89

Asian

3

4.35(0.91-20.92)

0.07/0.00

11.85(4.77-29.48)

0.00/0.07

3.59(1.06-12.18)

0.04/0.00

Study design

      

 HCC

2

1.31(0.83-2.08)

0.24/0.89

6.99(0.70-69.68)

0.10/0.66

1.38(0.91-2.08)

0.13/0.79

 PCC

3

3.58(0.94-13.62)

0.06/0.00

11.85(4.77-29.48)

0.00/0.07

3.10(1.08-8.87)

0.04/0.00

Sample size

      

Smaller

2

1.37(0.89-2.10)

0.14/0.92

6.99(0.70-69.68)

0.10/0.66

1.42(0.96-2.09)

0.08/0.89

Larger

3

4.35(0.91-20.92)

0.07/0.00

11.85(4.77-29.48)

0.00/0.07

3.59(1.06-12.18)

0.04/0.00

  1. n, number of studies in each analysis; HCC, Hospital based case–control study; PCC, population based case–control study; OR, odds ratio; CI, confi dence interval; p, p value for each test; Phet, p -value for heterogeneity test.